Author Question: What should the nurse explain to a client with Addison disease as the reason for needing ... (Read 48 times)

EY67

  • Hero Member
  • *****
  • Posts: 531
What should the nurse explain to a client with Addison disease as the reason for needing mineralocorticoid replacement therapy?
 
  1. Mineralocorticoids will reduce excessive serum glucose levels.
  2. Mineralocorticoids will mimic the action of cortisol.
  3. Mineralocorticoids will mimic the action of aldosterone.
  4. Mineralocorticoids will reduce harmful bronzing of the skin.

Question 2

The nurse would question the administration of mineralocorticoid replacement therapy for which client?
 
  1. Client with a defect in the stimulation of aldosterone secretion
  2. Client with a defect in aldosterone sensitivity
  3. Client with a defect in the secretion of aldosterone
  4. Client with Conn syndrome



pratush dev

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Correct Answer: 3
Rationale 1: This is not an indication for use of mineralocorticoids.
Rationale 2: Mineralocorticoids do not mimic the action of cortisol.
Rationale 3: Mineralocorticoids, in addition to glucocorticoids, are indicated for use in clients with adrenocortical insufficiency.
Rationale 4: Bronzing of the skin would not be affected by the use of mineralocorticoids, and is not harmful to clients with Addison disease.
Global Rationale: Mineralocorticoids, in addition to glucocorticoids, are indicated for use in clients with adrenocortical insufficiency. They do not mimic the action of cortisol or affect the bronzing of the skin. Serum glucose levels are not affected.

Answer to Question 2

Correct Answer: 4
Rationale 1: This client should receive mineralocorticoid replacement.
Rationale 2: This client should receive mineralocorticoid replacement.
Rationale 3: This client should receive mineralocorticoid replacement.
Rationale 4: A client with Conn syndrome already has oversecretion of aldosterone and does not require mineralocorticoid replacement therapy.
Global Rationale: A client with Conn syndrome already has oversecretion of aldosterone and does not require mineralocorticoid replacement therapy. Mineralocorticoid replacement is used to treat the other conditions.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

For a complete list of videos, visit our video library